News
December 13, 2020
Over recent weeks and months, we have been in constant discussions with key industry stakeholders and partners to stay abreast of the challenges and complexities facing the different segments of the Pharma industry in the face of disruption due to COVID-19. This has included working closely with all partners directly involved with CPhI Worldwide 2020 to determine if the show scheduled for October in Milan would have been both practical […]
December 13, 2020
Compendia: USP Appearance: Yellow to orange crystalline powder Solubility: Practically Insoluble in water, very slightly soluble in Ethanol Assay: > 99.0 % Origin: USA Packing: 5 kg Aluminium tins Benefits: CoQ10 has been shown to help improve heart health and blood sugar regulation, assist in the prevention and treatment of cancer and reduce the frequency of migraines. It could also reduce the oxidative damage that leads to muscle fatigue, skin […]
December 9, 2020
In addition to the active pharmaceutical ingredient, drug formulations contain excipients such as stabilizers, colourants and antioxidants, which are designated as ‘inactive’. However, writing in Science, researchers from academia and industry now report that many commonly used excipients are active at physiologically relevant targets, suggesting more attention should be paid to these often-overlooked drug components. The FDA’s Inactive Ingredients Database (IID) lists more than 3,000 excipients, which are considered inactive […]
July 24, 2020
Over recent weeks and months, we have been in constant discussions with key industry stakeholders and partners to stay abreast of the challenges and complexities facing the different segments of the Pharma industry in the face of disruption due to COVID-19. This has included working closely with all partners directly involved with CPhI Worldwide 2020 to determine if the show scheduled for October in Milan would have been both practical […]
July 5, 2020
COVID-19 has rekindled debate about pharmaceutical supply chains and prompted renewed calls for drug companies to source more active pharmaceutical ingredients (APIs) from the US and Europe. China is a major API, raw materials and intermediates supplier, and according to US Food and Drug Administration (FDA), 13% of the plants supplying APIs for US drugs are in China [1]. Likewise, many European pharmaceutical companies rely on China for APIs. Also, […]
June 26, 2020
It would be disingenuous to claim 2019 was a revolutionary year for pharma as it continues its journey towards a patient-centric model. The twin objectives of unlocking innovative potential to bring new products to market and bettering patient lives in a rapidly evolving global landscape remain unchanged. The journey is well underway, and companies are in the process of mapping out how they reach this futuristic destination. Trends to look […]
